NDC Code(s) : 49349-212-02
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Loxapine SuccinateLoxapine Succinate CAPSULE | ||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: Loxapine
GENERIC: Loxapine
DOSAGE: CAPSULE
ADMINSTRATION: ORAL
NDC: 49349-212-02
COLOR: white
SHAPE: CAPSULE
SCORE: No score
SIZE: 19 mm
IMPRINT: Watson;372;50;mg
PACKAGING: 30 in 1 BLISTER PACK
ACTIVE INGREDIENT(S):
- LOXAPINE SUCCINATE 50mg in 1
INACTIVE INGREDIENT(S):
- ANHYDROUS LACTOSE
- PROPYLPARABEN
- SODIUM LAURYL SULFATE
- POLACRILIN POTASSIUM
- SODIUM PROPIONATE
- TALC
- TITANIUM DIOXIDE
- BENZYL ALCOHOL
- BUTYLPARABEN
- EDETATE CALCIUM DISODIUM
- FD&C BLUE NO. 1
- GELATIN
- MAGNESIUM STEARATE
- METHYLPARABEN